Therapeutic potential of nicotinamide and ABT263 in alcohol‐associated liver disease through targeting cellular senescence
MedComm · 2025-02 · 6 (2)
DOI: 10.1002/mco2.70086 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 09.02.2025. Verfasst von Naheemat Modupeola Gold und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Evolution & Animal Models Key Laboratory of Healthy Aging Research of Yunnan Province Kunming Institute of Zoology Ch…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Alcohol‐associated liver disease (ALD) is a major cause of liver‐related morbidity and mortality, yet clinically effective therapies for ALD remain lacking. Here, we demonstrate that alcohol intake and its metabolite, acetaldehyde (ACH), induce senescence in the liver and liver cells, respectively. To assess the therapeutic potential of targeting liver senescence in ALD, we treated ALD‐affected mice with the senolytic compound ABT263 and the senomorphic NAD + precursor, nicotinamide (NAM). The results show that ABT263 effectively clears senescent hepatocytes and stellate cells, and reduces liver triglyceride (TG), but increases plasma alanine aminotransferase and TG levels. Conversely, NAM efficiently suppresses senescence and the senescence‐associated secretory phenotype (SASP), protecting the liver from alcohol‐induced injury in ALD mice. RNA‐sequencing analysis revealed that ABT263 treatment downregulated genes involved in adipogenesis while activating the complement pathway. In contrast, NAM upregulated metabolism‐related genes, such as Sirt1 , and downregulated DNA damage marker genes, including Rec8 and E2f1 , in the liver. These findings suggest that cellular senescence plays a critical role in alcohol‐induced liver injury. Compared with senescent cell clearance by ABT263, suppressing senescence and SASP by NAM may provide a safer and more effective therapeutic approach for ALD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Genetic Evolution & Animal Models Key Laboratory of Healthy Aging Research of Yunnan Province Kunming Institute of Zoology Chinese Academy of Sciences Kunming Yunnan China.
- Kunming College of Life Science University of Chinese Academy of Sciences Kunming China.
- Department of Nutrition and Food Hygiene, School of Public Health Zhejiang Chinese Medical University Hangzhou Zhejiang China.
- Department of Medicine Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA.
- Biodiversity Data Center of Kunming Institute of Zoology Chinese Academy of Sciences Kunming Yunnan China.
- Guangdong Key Laboratory of Nanomedicine Institute of Biomedicine and Biotechnology Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen China.
ORCID-Profile: Yonghan He
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Gold, N. M., Ding, Q., Yang, Y., Pu, S., Cao, W., Ge, X., Yang, P., Okeke, M. N., Nisar, A., Pan, Y., Luo, Q., Wang, X., Xu, H., Tian, R., Zi, M., Zhang, X., Li, S., & He, Y. (2025). Therapeutic potential of nicotinamide and ABT263 in alcohol‐associated liver disease through targeting cellular senescence. MedComm, 6(2). https://doi.org/10.1002/mco2.70086
Vancouver
Gold NM, Ding Q, Yang Y, Pu S, Cao W, Ge X, et al. Therapeutic potential of nicotinamide and ABT263 in alcohol‐associated liver disease through targeting cellular senescence. MedComm. 2025;6(2). doi:10.1002/mco2.70086
BibTeX
@article{Gold2025,
author = {Gold, Naheemat Modupeola and Ding, Qinchao and Yang, Yang and Pu, Shaoyan and Cao, Wenjing and Ge, Xinxuan and Yang, Pengyun and Okeke, Michael Ngozi and Nisar, Ayesha and Pan, Yongzhang and Luo, Qiuni and Wang, Xiayan and Xu, Han and Tian, Rui and Zi, Meiting and Zhang, Xingjie and Li, Songtao and He, Yonghan},
title = {Therapeutic potential of nicotinamide and ABT263 in alcohol‐associated liver disease through targeting cellular senescence},
journal = {MedComm},
year = {2025},
volume = {6},
number = {2},
doi = {10.1002/mco2.70086}
}
EUVIMED